ReNerve Shareholder Newsletter August 2021
Some notable highlights : Presentation of ReNerve at the Royal Australian College of Surgeons Annual Scientific Meeting in Melbourne Launch… Read more
ReNerve – NervAlign products wow surgeons at their annual scientific congress
ReNerve showcased its novel tissue-based products at the Royal Australasian College of Surgeons’ Annual Scientific Congress, held in Melbourne in… Read more
ReNerve and VivaZome enter collaboration in spinal cord repair.
ReNerve Ltd (ReNerve) and VivaZome Therapeutics Pty Ltd (VivaZome) today announced that they have entered a collaboration to combine their… Read more
Company Presentation – May 2021
Major progress on FDA marketing approval application – UPDATE
The company has had several rounds of questions and interactions with the FDA and believes it is now in the… Read more
ReNerve completes highly sought $2M Capital Raising
ReNerve Limited is an Australian public unlisted medical device company dedicated to developing genuine solutions to peripheral nerve repair and… Read more
ReNerve Newsletter April 2020
ReNerve completed a capital raising in March 2020, with the company raising just over $1.1M in new equity. As a… Read more
ReNerve Newsletter Sept 2019
ReNerve continues to make progress towards developing products for the global nerve repair and replacement market.